Chronic pruritus is a multifaceted issue of our time

Cover Page

Cite item

Full Text

Abstract

Chronic pruritus still causes difficulties not only for patients, but also for physicians. Dermatological diseases are the major cause of itching, however the list of triggers causing pruritus is much longer. Thus, many chronic diseases can be accompanied by itching, which has its own features. In some liver disorders (cholangitis, viral hepatitis), generalized pruritus often develops. Uremic pruritus in chronic kidney disease occurs in 50% of dialysis patients. Patients with diabetes mellitus also sometimes experience chronic pruritus that gets worse at night. Neuropathic pruritus is often accompanied by other discomforts, such as numbness or mild pain. Also, it should not be ruled out that a drug can become the cause of itching. The reaction to the drug can occur immediately or be delayed. With such a wide list of underlying causes of pruritus, its diagnosis and therapy becomes a complex task and requires the participation of several specialists to select the optimal therapy.

About the authors

Anastas L. Piruzyan

Center for Theoretical Problems of Physicochemical Pharmacology

д-р мед. наук, проф., гл. науч. сотр Moscow, Russia

Zofiia A. Nevozinskaia

Moscow Scientific and Practical Center for Dermatovenereology and Cosmetology, Moscow

канд. мед. наук, врач-дерматовенеролог Moscow, Russia

Irina M. Korsunskaya

Center for Theoretical Problems of Physicochemical Pharmacology

Email: marykor@bk.ru
д-р мед. наук, проф., зав. лаб. Moscow, Russia

References

  1. Hafenreffer S. Nosodochium, In Quo Cutis, Eique Adhaerentium Parti um, Affectus Omnes, Singulari Methodo, Et Cognoscendi Et Curandi Fidelissime Tradunturkuhnen, Reipubl Ibid Typogr & Biblopo-lae (Typis & Expensis Balthasar, Ulm, 1660). Misery, L. & Stander, S. Pruritus (Springer, London, 2010).
  2. Misery L et al. Neuropathic pruritus. Nat Rev Neurol 2014; 10: 408-16. doi: 10.1038/nrneurol.2014.99
  3. Misery L, Dutray S, Chastaing M et al. Psychogenic itch. Transl Psychiatry 2018; 8 (1): 52. doi: 10.1038/s41398-018-0097-7
  4. Stander S, Pogatzki-Zahn E, Stumpf A et al. Facing the challenges of chronic pruritus: a report from a multi-disciplinary medical itch centre in Germany. Acta Derm Venereol 2015; 95: 266-71.
  5. Dull MM, Kremer AE. Management of chronic hepatic itch. Dermatol Clin 2018; 36: 293-300.
  6. Bergasa NV, Mehlman JK, Jones EA. Pruritus and fatigue in primary biliary cirrhosis. Baillieres Best Pract Res Clin Gast-roenterol 2000; 14: 643-55
  7. Weiss M, Mettang T, Tschulena U et al. Prevalence of chronic itch and associated factors in haemodialysis patients: a representative cross-sectional study. Acta Derm Venereol 2015; 95: 816-21.
  8. Rayner HC, Larkina M, Wang M et al. International comparisons of pre-valence, awareness, and treatment of pruritus in people on hemodialysis. Clin J Am Soc Nephrol 2017; 12: 2000-7.
  9. Khanna D, Singal A, Kalra OP. Comparison of cutaneous manifestations in chronic kidney disease with or without dialysis. Postgrad Med J 2010; 86: 641-7.
  10. Ko MJ, Chiu HC, Jee SH et al. Postprandial blood glucose is associated with generalized pruritus in patients with type 2 diabetes. Eur J Dermatol 2013; 23: 688-93
  11. Yamaoka H, Sasaki H, Yamasaki H et al. Truncal pruritus of unknown origin may be a symptom of diabetic polyneuropathy. Diabetes Care 2010; 33: 150-5.
  12. Marziniak M, Phan NQ, Raap U et al. Brachioradial pruritus as a result of cervical spine pathology: the results of a magnetic resonance tomography study. J Am Acad Dermatol 2011; 65: 756-62.
  13. Lauria G, Bakkers M, Schmitz C et al. Intraepidermal nerve fiber density at the distal leg: a worldwide normative reference study. J Peripher Nerv Syst 2010; 15: 202-7.
  14. Reich A, Stander S, Szepietowski JC. Drug-induced pruritus: a review. Acta Derm Venereol 2009; 89 (3): 236-44. doi: 10.2340/00015555-0650
  15. Raksha MP, Marfatia YS. Clinical study of cutaneous drug eruptions in 200 patients. Indian J Dermatol Venereol Leprol 2008; 74: 80.
  16. Shirin H, Schapiro JM, Arber N et al. Erythromycin base-induced rash and liver function disturbances. Ann Pharmacother 1992; 26: 1522-3.
  17. Morton A, Muir J, Lim D. Rash and acute nephritic syndrome due to candesartan. BMJ 2004; 328: 25.
  18. Miro N. Controlled multicenter study on chronic suppurative otitis media treated with topical applications of ciprofloxacin 0.2% solution in single-dose containers or combination of polymyxin B, neomycin, and hydrocortisone suspension. Otolaryngol Head Neck Surg 2000; 123: 617-23.
  19. Szepietowski J, Reich A, Biatynicki-Birula R. Itching in atopic dermatitis: clinical manifestation, pathogenesis and the role of pimecrolimus in itch reduction. Dermatol Klin 2004; 6: 173-6.
  20. Abramovits W, Boguniewicz M. Adult Atopiclair Study Group A multicenter, randomized, vehicle-controlled clinical study to examine the efficacy and safety of MAS063DP (Atopiclair) in the management of mild to moderate atopic dermatitis in adults. J Drug Dermatol 2006; 5: 236-44.
  21. Seiwerth J, Tasiopoulou G, Hoffmann J et al. Anti-Inflammatory Effect of a Novel Topical Herbal Composition (VEL-091604) Consisting of Gentian Root, Licorice Root and Willow Bark Extract. Planta Med 2019; 85: 608-14. doi: 10.1055/a-0835-6806

Copyright (c) 2020 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies